| Date Filed | Type | Description |
| 03/22/2023 |
4
| Carter Laura (Chief Scientific Officer) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 157,500 options to buy
@ $1.21, valued at
$190.6k
|
|
| 03/20/2023 |
4
| Carter Laura (Chief Scientific Officer) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Sold 6,029 shares
@ $1.098, valued at
$6.6k
|
|
| 12/09/2022 |
4
| Carter Laura (Chief Scientific Officer) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 157,500 options to buy
@ $2.16, valued at
$340.2k
|
|
| 10/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| Carter Laura (Chief Scientific Officer) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 190,000 options to buy
@ $11.94, valued at
$2.3M
|
|
| 10/26/2021 |
4
| Carter Laura (Chief Scientific Officer) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Sold 2,377 shares
@ $12.25, valued at
$29.1k
|
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |